EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. EXEL

Equity Profile

EXEL

Exelixis, Inc.

Health CareBiotechnology$14.5B market cap

Earnings scorecard

Last 76Q

EPS beat streak

9Q

EPS beat rate

68%

Avg EPS surprise

+77.56%

Avg 1-day reaction

-1.00%

Earnings history

77 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingOct 27, 2026————Preview
Q2-2026Aug 5, 2026$0.86$0.91+21.01%+1.25%Preview
Q1-2026May 5, 2026$0.76$0.87+29.27%+0.57%Preview
Q4-2025Feb 10, 2026$0.68$0.94+38.85%-2.21%Preview
Q3-2025Nov 4, 2025$0.58$0.78+33.33%-0.42%Preview
Q2-2025Jul 28, 2025ProPreview
Q1-2025May 13, 2025ProPreview
Q4-2024Feb 11, 2025ProPreview
Q3-2024Oct 29, 2024ProPreview
Q2-2024Aug 6, 2024ProPreview
Q1-2024Apr 30, 2024ProPreview
Q4-2023Feb 6, 2024ProPreview
Q3-2023Nov 1, 2023ProPreview
Q2-2023Aug 1, 2023ProPreview
Q1-2023May 9, 2023ProPreview
Q4-2022Feb 7, 2023ProPreview
Q3-2022Nov 1, 2022ProPreview
Q2-2022Aug 9, 2022ProPreview
Q1-2022May 10, 2022ProPreview
Q4-2021Feb 17, 2022ProPreview
Q3-2021Nov 2, 2021ProPreview
Q2-2021Aug 5, 2021ProPreview
Q1-2021May 6, 2021ProPreview
Q4-2020Feb 10, 2021ProPreview
Q3-2020Nov 5, 2020ProPreview
Q2-2020Aug 6, 2020ProPreview
Q1-2020May 5, 2020ProPreview
Q4-2019Feb 25, 2020ProPreview
Q3-2019Oct 30, 2019ProPreview
Q2-2019Jul 31, 2019ProPreview
Q1-2019May 1, 2019ProPreview
Q4-2018Feb 12, 2019ProPreview
Q3-2018Nov 1, 2018ProPreview
Q2-2018Aug 1, 2018ProPreview
Q1-2018May 2, 2018ProPreview
Q4-2017Feb 26, 2018ProPreview
Q3-2017Nov 1, 2017ProPreview
Q2-2017Aug 2, 2017ProPreview
Q1-2017May 1, 2017ProPreview
Q4-2016Feb 27, 2017ProPreview
Q3-2016Nov 3, 2016ProPreview
Q2-2016Aug 3, 2016ProPreview
Q1-2016May 4, 2016ProPreview
Q4-2015Feb 29, 2016ProPreview
Q3-2015Nov 10, 2015ProPreview
Q2-2015Aug 11, 2015ProPreview
Q1-2015Apr 30, 2015ProPreview
Q4-2014Feb 24, 2015ProPreview
Q3-2014Nov 4, 2014ProPreview
Q2-2014Jul 31, 2014ProPreview
Q1-2014May 1, 2014ProPreview
Q4-2013Feb 20, 2014ProPreview
Q3-2013Oct 30, 2013ProPreview
Q2-2013Aug 6, 2013ProPreview
Q1-2013May 7, 2013ProPreview
Q4-2012Feb 21, 2013ProPreview
Q3-2012Nov 7, 2012ProPreview
Q2-2012Aug 2, 2012ProPreview
Q1-2012May 3, 2012ProPreview
Q4-2011Feb 8, 2012ProPreview
Q3-2011Oct 27, 2011ProPreview
Q2-2011Aug 4, 2011ProPreview
Q1-2011May 3, 2011ProPreview
Q4-2010Feb 22, 2011ProPreview
Q3-2010Nov 4, 2010ProPreview
Q2-2010Aug 5, 2010ProPreview
Q1-2010May 11, 2010ProPreview
Q4-2009Mar 9, 2010ProPreview
Q3-2009Oct 29, 2009ProPreview
Q2-2009Jul 30, 2009ProPreview
Q1-2009May 7, 2009ProPreview
Q4-2008Mar 4, 2009ProPreview
Q3-2008Oct 27, 2008ProPreview
Q2-2008Aug 5, 2008ProPreview
Q1-2008May 6, 2008ProPreview
Q4-2007Feb 14, 2008ProPreview
Q3-2007Nov 5, 2007ProPreview

Next report

Q3-2026

Tue, Oct 27

After the close

Est. EPS

—

Est. Rev

—

Read the preview

About EXEL

Sector
Health Care
Industry
Biotechnology
Market cap
$14.5B

72 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Jul 28, 2025ProPreview
Q1-2025May 13, 2025ProPreview
Q4-2024Feb 11, 2025Pro
Preview
Q3-2024Oct 29, 2024ProPreview
Q2-2024Aug 6, 2024ProPreview
Q1-2024Apr 30, 2024ProPreview
Q4-2023Feb 6, 2024ProPreview
Q3-2023Nov 1, 2023ProPreview
Q2-2023Aug 1, 2023ProPreview
Q1-2023May 9, 2023ProPreview
Q4-2022Feb 7, 2023ProPreview
Q3-2022Nov 1, 2022ProPreview
Q2-2022Aug 9, 2022ProPreview
Q1-2022May 10, 2022ProPreview
Q4-2021Feb 17, 2022ProPreview
Q3-2021Nov 2, 2021ProPreview
Q2-2021Aug 5, 2021ProPreview
Q1-2021May 6, 2021ProPreview
Q4-2020Feb 10, 2021ProPreview
Q3-2020Nov 5, 2020ProPreview
Q2-2020Aug 6, 2020ProPreview
Q1-2020May 5, 2020ProPreview
Q4-2019Feb 25, 2020ProPreview
Q3-2019Oct 30, 2019ProPreview
Q2-2019Jul 31, 2019ProPreview
Q1-2019May 1, 2019ProPreview
Q4-2018Feb 12, 2019ProPreview
Q3-2018Nov 1, 2018ProPreview
Q2-2018Aug 1, 2018ProPreview
Q1-2018May 2, 2018ProPreview
Q4-2017Feb 26, 2018ProPreview
Q3-2017Nov 1, 2017ProPreview
Q2-2017Aug 2, 2017ProPreview
Q1-2017May 1, 2017ProPreview
Q4-2016Feb 27, 2017ProPreview
Q3-2016Nov 3, 2016ProPreview
Q2-2016Aug 3, 2016ProPreview
Q1-2016May 4, 2016ProPreview
Q4-2015Feb 29, 2016ProPreview
Q3-2015Nov 10, 2015ProPreview
Q2-2015Aug 11, 2015ProPreview
Q1-2015Apr 30, 2015ProPreview
Q4-2014Feb 24, 2015ProPreview
Q3-2014Nov 4, 2014ProPreview
Q2-2014Jul 31, 2014ProPreview
Q1-2014May 1, 2014ProPreview
Q4-2013Feb 20, 2014ProPreview
Q3-2013Oct 30, 2013ProPreview
Q2-2013Aug 6, 2013ProPreview
Q1-2013May 7, 2013ProPreview
Q4-2012Feb 21, 2013ProPreview
Q3-2012Nov 7, 2012ProPreview
Q2-2012Aug 2, 2012ProPreview
Q1-2012May 3, 2012ProPreview
Q4-2011Feb 8, 2012ProPreview
Q3-2011Oct 27, 2011ProPreview
Q2-2011Aug 4, 2011ProPreview
Q1-2011May 3, 2011ProPreview
Q4-2010Feb 22, 2011ProPreview
Q3-2010Nov 4, 2010ProPreview
Q2-2010Aug 5, 2010ProPreview
Q1-2010May 11, 2010ProPreview
Q4-2009Mar 9, 2010ProPreview
Q3-2009Oct 29, 2009ProPreview
Q2-2009Jul 30, 2009ProPreview
Q1-2009May 7, 2009ProPreview
Q4-2008Mar 4, 2009ProPreview
Q3-2008Oct 27, 2008ProPreview
Q2-2008Aug 5, 2008ProPreview
Q1-2008May 6, 2008ProPreview
Q4-2007Feb 14, 2008ProPreview
Q3-2007Nov 5, 2007ProPreview